According to Antares Pharma's latest financial reports the company's current EPS (TTM) is $0.45. In 2020 the company made an earnings per share (EPS) of $0.45 an increase over its 2019 EPS that were of -$0.01319.
Year | EPS | Change |
---|---|---|
2020 | $0.45 | -3500% |
2019 | -$0.01319 | -75% |
2018 | -$0.05274 | -63.64% |
2017 | -$0.15 | -31.25% |
2016 | -$0.21 | 14.29% |
2015 | -$0.18 | -48.15% |
2014 | -$0.36 | 68.75% |
2013 | -$0.21 | 60% |
2012 | -$0.13 | 100% |
2011 | -$0.06593 | -28.57% |
2010 | -$0.09230 | -50% |
2009 | -$0.18 | -26.32% |
2008 | -$0.25 | 35.71% |
2007 | -$0.18 | -12.5% |
2006 | -$0.21 | -23.81% |
2005 | -$0.28 | -8.7% |
2004 | -$0.30 | -89.45% |
2003 | -$2.87 | 78.69% |
2002 | -$1.61 | -30.68% |
2001 | -$2.32 | -49.13% |
2000 | -$4.56 | 28.15% |
1999 | -$3.56 | -33.66% |
1998 | -$5.37 | 93.81% |
1997 | -$2.77 | 7.69% |
1996 | -$2.57 |